PaxMedica, Inc. Common Stock
PXMD · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $6 | $5 |
| - Cash | $0 | $2 | $5 | $1 |
| + Debt | $0 | $0 | $0 | $2 |
| Enterprise Value | $1 | $2 | $1 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$6 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$4 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.39 | -0.5 | -0.8 | -5.2 |
| % Growth | 22% | 37.5% | 84.6% | – |
| Operating Cash Flow | -$1 | -$3 | -$3 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$3 | -$3 | -$2 |